VRDN - Company ID 0001590750
As of 2026-11-06, Viridian Therapeutics, Inc.DE (VRDN) has a market capitalization of $2.97 B, making it the #1817 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $2.97 B |
| 2026-11-05 | $2.94 B |
| 2026-11-04 | $2.99 B |
| 2026-11-03 | $2.63 B |
| 2026-11-02 | $2.61 B |
| 2026-11-01 | $2.54 B |
| 2026-10-31 | $2.54 B |
| 2026-10-30 | $2.54 B |
| 2026-10-29 | $2.56 B |
| 2026-10-28 | $2.50 B |
| 2026-10-27 | $2.47 B |
| 2026-10-26 | $2.38 B |
As of 2026-11-06, Viridian Therapeutics, Inc.DE (VRDN) has a market capitalization of $2.97 B, making it the #1817 most valuable US-listed company.
Viridian Therapeutics, Inc.DE is the #1817 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $2.31 B |
| 2026-10-24 | $2.31 B |
| 2026-10-23 | $2.31 B |
| 2026-10-22 | $2.35 B |
| 2026-10-21 | $2.37 B |
| 2026-10-20 | $2.31 B |
| 2026-10-19 | $2.14 B |
| 2026-10-18 | $1.96 B |
| 2026-10-17 | $1.96 B |
| 2026-10-16 | $1.96 B |
| 2026-10-15 | $2.02 B |
| 2026-10-14 | $1.90 B |
| 2026-10-13 | $1.88 B |
| 2026-10-12 | $1.89 B |
| 2026-10-11 | $1.92 B |
| 2026-10-10 | $1.92 B |
| 2026-10-09 | $1.91 B |
| 2026-10-08 | $1.89 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.